久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Spark Therapeutics Earns $15M Pfizer Milestone contractpharma
    January 06, 2017
    Spark Therapeutics has earned a $15 million milestone payment from Pfizer for achieving a pre-specified safety and efficacy profile in the ongoing hemophilia B Phase 1/2 trial of SPK-9001.
PharmaSources Customer Service